FDA Inspection 897244 — Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.
The FDA completed an inspection of Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd. on September 26, 2014 in Singapore. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 26, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Singapore (Singapore)